MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 72,401 shares at $27.99 ($2.0M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Scheduled sale ($2.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 17,938 | $493K | 24.6% |
| 2 | $27.99 | 3,623 | $101K | 5.0% |
| 3 | $27.99 | 3,623 | $101K | 5.0% |
| 4 | $27.79 | 23,113 | $642K | 32.0% |
| 5 | $27.79 | 23,113 | $642K | 32.0% |
| 6 | $28.15 | 991 |
| $28K |
| 1.4% |
| Total | $27.74 avg | 72,401 | $2.0M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |